Gravier Pierre bought PTCT
January 2, 2026 · Form 4 insider transaction
Gravier Pierre bought 20,000 shares of PTC Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
20,000
Price
$0.00
Total value
N/A
InsiderGravier Pierre
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJanuary 2, 2026
Filing dateJanuary 6, 2026
Shares owned after92,449
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Restricted stock units granted on January 2, 2026 that vest in four equal installments over four years, commencing on January 2, 2027.; Includes 272 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended June 30, 2025, and 257 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended December 31, 2025.